Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

Clinical trial NCT00202280 · COMPLETED

Trial details

NCT number: NCT00202280
Sponsor: Melbourne Health
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

First Episode Psychosis

Start date: 2004-09-01
Primary completion: 2006-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.